OCT 27, 2026 · JOURNAL ARTICLE
ESR1 mutations and endocrine resistance in ER-positive breast cancer: Molecular mechanisms, liquid biopsy, and emerging targeted therapies
Indian Journal of Cancer
ABSTRACT: Estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer is the most common type of breast cancer, and endocrine therapy r